Literature DB >> 17275193

Involvement of prostaglandin E(2) derived from enteric glial cells in the action of bradykinin in cultured rat myenteric neurons.

M Murakami1, T Ohta, K-I Otsuguro, S Ito.   

Abstract

We characterized bradykinin (BK)-induced changes in the intracellular Ca(2+) concentration ([Ca(2+)]i) and membrane potential in cultured rat myenteric neurons using ratiometric Ca(2+) imaging with fura-2 and the whole-cell patch-clamp technique, respectively. BK evoked a dose-dependent increase of [Ca(2+)]i that was abolished by HOE 140, a B2 receptor antagonist but not by [Lys-des-Arg(9)]-BK, a B1 receptor antagonist. [Lys-des-Arg(9)]-HOE140, a B1 receptor agonist, failed to cause a [Ca(2+)]i response. Double staining with antibodies against the B2 receptor together with PGP9.5 or S100 indicated that B2 receptors were expressed in neurons and glial cells. The BK-evoked [Ca(2+)]i increase was suppressed by indomethacin, a non-selective cyclooxygenase (COX) inhibitor, and potentiated by prostaglandin E(2) (PGE(2)). The release of PGE(2) from cultured myenteric plexus cells was increased by BK. BK induced a large increase in [Ca(2+)]i in neurons when myenteric plexus cells were cultured at the high density but not at the low density, and caused a small increase in [Ca(2+)]i in neurons when proliferation of enteric glial cells was suppressed. BK evoked a slow and sustained depolarization in myenteric neurons, which was sensitive to indomethacin. These results indicated that BK caused a [Ca(2+)]i increase and depolarization in rat myenteric neurons through the activation of B2 receptors, which was partly associated with PGE(2) released from glial cells in response to BK. It is suggested that a neuron-glial interaction plays an important role in the effect of BK in the rat myenteric plexus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275193     DOI: 10.1016/j.neuroscience.2006.12.052

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

Review 1.  Emerging roles for enteric glia in gastrointestinal disorders.

Authors:  Keith A Sharkey
Journal:  J Clin Invest       Date:  2015-02-17       Impact factor: 14.808

Review 2.  Enteric glia regulate gut motility in health and disease.

Authors:  Vladimir Grubišić; Alexei Verkhratsky; Robert Zorec; Vladimir Parpura
Journal:  Brain Res Bull       Date:  2017-03-29       Impact factor: 4.077

3.  Cholinergic activation of enteric glia is a physiological mechanism that contributes to the regulation of gastrointestinal motility.

Authors:  Ninotchska M Delvalle; David E Fried; Gretchen Rivera-Lopez; Luke Gaudette; Brian D Gulbransen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

Review 4.  Enteric glial biology, intercellular signalling and roles in gastrointestinal disease.

Authors:  Luisa Seguella; Brian D Gulbransen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-17       Impact factor: 46.802

Review 5.  A model of the enteric neural circuitry underlying the generation of rhythmic motor patterns in the colon: the role of serotonin.

Authors:  Terence Keith Smith; Sang Don Koh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-10-27       Impact factor: 4.052

6.  The arachidonic acid metabolite 11β-ProstaglandinF2α controls intestinal epithelial healing: deficiency in patients with Crohn's disease.

Authors:  Sabrina Coquenlorge; Laurianne Van Landeghem; Julie Jaulin; Nicolas Cenac; Nathalie Vergnolle; Emilie Duchalais; Michel Neunlist; Malvyne Rolli-Derkinderen
Journal:  Sci Rep       Date:  2016-05-03       Impact factor: 4.379

7.  Tumor cells hijack enteric glia to activate colon cancer stem cells and stimulate tumorigenesis.

Authors:  Simon Valès; Gregory Bacola; Mandy Biraud; Mélissa Touvron; Anne Bessard; Fanny Geraldo; Kelsie A Dougherty; Shaian Lashani; Céline Bossard; Mathurin Flamant; Emilie Duchalais; Séverine Marionneau-Lambot; Thibauld Oullier; Lisa Oliver; Michel Neunlist; François M Vallette; Laurianne Van Landeghem
Journal:  EBioMedicine       Date:  2019-10-26       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.